FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

16 letters match. Newest first.

  1. DesBio/Deseret Biologicals, Inc.

    FDA says DesBio’s CHLA:10M, sold online for Chlamydia symptoms, is an unapproved new drug.

    High risk
  2. Royal Peptides LLC

    FDA warned Royal Peptides LLC that seven peptide products sold on its website are unapproved new drugs.

    High risk
  3. ImmunityBio, Inc.

    FDA says ImmunityBio's Anktiva TV ad and podcast falsely claim it can cure or prevent all cancers.

    High risk
  4. CSL Behring

    FDA says CSL Behring's HIZENTRA TV ad overstates protection and plays down risks, misbranding the immune globulin biologic.

    Medium
  5. Eli Lilly and Company

    FDA says Eli Lilly’s Oprah-linked video for Zepbound and Mounjaro misled on serious risks.

    High risk
  6. Novo Nordisk Inc.

    FDA says Novo Nordisk’s Oprah Winfrey video makes Wegovy, Ozempic and Victoza look safer than their labels allow.

    High risk
  7. Eli Lilly and Company

    FDA says Eli Lilly's Zepbound online video omitted risk and limitations information and was not submitted to FDA.

    High risk
  8. Eli Lilly and Company

    FDA says Eli Lilly's sponsored Zepbound video omitted risk and use information, misbranding the drug.

    Low
  9. Reset Technology Corporation

    FDA warns Reset Technology about missing validation and complaint handling for ResetSmile dental devices.

    High risk
  10. Human Microbes

    FDA warned Human Microbes that selling fecal microbiota for transplantation as an unapproved drug and unlicensed biologic lacks required BLA or IND.

    High risk
  11. Vivera Pharmaceuticals, Inc.

    Vivera Pharmaceuticals sold a COVID-19 home specimen collection kit directly to consumers without FDA approval, clearance, or authorization.

    High risk
  12. Biopolygen Corp.

    FDA warned Biopolygen Corp. for selling three unapproved COVID-19 self-test kits directly to consumers online.

    High risk
  13. Baltimore Beauty Security Square Mall

    Baltimore Beauty offered GenBody COVID-19 test kits directly to consumers without FDA approval, clearance, or authorization.

    High risk
  14. Fast Masks USA LLC

    Fast Masks USA sold unapproved at-home COVID-19 test kits and claimed they were FDA approved or authorized, FDA says.

    High risk
  15. Tresmonet Technologies, Inc., TM Testing, Inc. dba TM Technologies, Inc./TM Labs

    FDA warned Tresmonet/TM Labs over selling an unapproved, misbranded at-home COVID-19 antibody test and claiming FDA approval.

    High risk
  16. CooperSurgical, Inc.

    FDA says CooperSurgical’s Paragard video omitted all risk information, making the birth-control promotion misleading and misbranded.

    Low